| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.7M | -12.5% |
| Cost of Revenue | $3.4M | -14.3% |
| Gross Profit | $4.3M | -10.9% |
| R&D Expense | $720K | -1.6% |
| SG&A Expense | $8.2M | -20.9% |
| Operating Income | -$6.0M | +27.3% |
| Pre-tax Income | -$925K | +94.0% |
| Income Tax | $3K | -90.3% |
| Net Income | -$928K | +94.0% |
| EPS (Basic) | -$0.08 | +96.4% |
| EPS (Diluted) | -$0.08 | +96.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.2M | +744.2% |
| Accounts Receivable | $1.3M | -11.4% |
| Current Assets | $6.3M | -61.3% |
| Total Assets | $7.5M | -53.4% |
| Current Liabilities | $20.0M | +85.3% |
| Long-term Debt | $300K | -98.2% |
| Total Liabilities | $22.1M | +104.4% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.5M | -151.2% |
| Capital Expenditures | $53K | +253.3% |
| Investing Cash Flow | -$165K | +6.3% |
| Financing Cash Flow | $9.4M | +260.6% |
| Free Cash Flow | -$5.6M | -151.9% |
| -$14.6M |
| -36.3% |